Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
California-based medical device maker Cervel Neurotech is nearing the close of an $11.9 million funding round, having raised $11.1 million since April 2013 in support of its technology-based therapies for neurological and psychiatric disorders.
The company filed an amendment this month citing 8 unnamed investors participating in its financing round, which involved sales of equity, rights and securities. The fundraising, which is not associated with any other transaction, so far includes “a warrant, the exercise price of which has not been received, and may never be received,” Cervel reported. Read more
Medtronic has confirmed its plan to acquire wearable sensor maker Corventis, telling analysts last week that it expects to close the deal this month but declining to confirm a report that the buyout is worth more than $150 million.
Mike Coyle, president of Medtronic’s cardiac & vascular group, confirmed the Corventis buyout, 1st reported by Mobihealthnews in May, at the medical device company’s semi-annual analyst meeting in New York June 5. Read more
MASSDEVICE ON CALL — A team of French doctors were the 1st to implant a patient with a customized spinal cage, thanks to 3D printed technology and development by device maker Medicrea.
Medicrea’s UNiD system 1st creates 3D digital images of a patient’s spinal anatomy, using them as a blueprint to produce an inter-body device aligned perfectly to the patients’ spine. The cages separate the vertebrae to restore proper alignment, with a spinal screw for added stability. Read more